More Articles
Kardium, a Canadian medical device company focused on electrophysiology technologies, has raised $104 million in new financing. Fidelity Management and Research Company led the funding round; T. Rowe Price Associates and new investor…
The U.S. Food and Drug Administration (FDA) is warning Americans not to “eat, sell or serve” mushroom-laced chocolates sold by Diamond Shruumz. Sickness and hospitalizations after eating these…
Stuart Connolly, MD, a veteran cardiologist known for his groundbreaking work in the field of electrophysiology, died June 2 after a long battle with neuroendocrine cancer. He was 75 years old.
…
A new pulsed field ablation (PFA) system from Kardium could give cardiologists a new tool in the war against atrial fibrillation (AFib), according to new data published in Heart Rhythm.[1…
WearLinq, a San Francisco-based healthcare technology company, has acquired AMI Cardiac Monitoring, an independent diagnostic testing facility, to help increase the reach of its…
The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse…
Atraverse Medical, a San Diego-based medical device company focused on left-heart technology, has received U.S. Food and Drug Administration (FDA) clearance for its Hotwire radiofrequency (RF)…
PaceMate, a Florida-based healthcare technology company focused on remote monitoring and data management for heart patients, has announced that…
Medtronic has added new artificial intelligence (AI) capabilities to its Reveal LINQ insertable cardiac monitor (ICM), the company announced Monday, May…
![Abbott’s Aveir DR leadless pacemaker, the world’s very first dual-chamber pacing solution of its kind, is associated with a “reliable” performance after six months, according to new data published in Heart Rhythm.[1]](/sites/default/files/styles/media_image/public/2024-05/screen_shot_2024-05-10_at_11.33.50_am.png.webp?h=3af9dcd6&itok=ZuCFBzfX)
…
A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024, the annual meeting of the Heart Rhythm Society (HRS). The meeting will take place May 16-19 in Boston.
…
Biosense Webster, a part of Johnson & Johnson MedTech, has released the latest version of its Carto 3 3D mapping software for cardiac ablation procedures. The update, officially known as Carto 3 System Version 8, includes new…
Apple Watch AFib feature becomes first-ever digital tool approved by FDA to evaluate medical devices
The Apple Watch’s atrial fibrillation (AFib) history feature has qualified for the FDA’s Medical Device Development Tools (MDDT) program, meaning…
Catheter ablation is known to benefit patients who present with atrial fibrillation (AFib) and heart failure with reduced ejection fraction (HFrEF). Its potential impact on patients with AFib and heart failure with preserved ejection…